These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37429512)

  • 21. Predicting mild cognitive impairment progression to Alzheimer's disease based on machine learning analysis of cortical morphological features.
    Wang W; Peng J; Hou J; Yuan Z; Xie W; Mao G; Pan Y; Shao Y; Shu Z
    Aging Clin Exp Res; 2023 Aug; 35(8):1721-1730. PubMed ID: 37405620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of Mild Cognitive Impairment Progression to Alzheimer's Disease Based on Diffusion Tensor Imaging-Derived Diffusion Parameters: Construction and Validation of a Nomogram.
    Cheng X; Li D; Peng J; Shu Z; Xing X
    Eur Neurol; 2023; 86(6):408-417. PubMed ID: 37926082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting Longitudinal Cognitive Decline and Alzheimer's Conversion in Mild Cognitive Impairment Patients Based on Plasma Biomarkers.
    Park MK; Ahn J; Kim YJ; Lee JW; Lee JC; Hwang SJ; Kim KC
    Cells; 2024 Jun; 13(13):. PubMed ID: 38994939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fine-Tuning Bidirectional Encoder Representations From Transformers (BERT)-Based Models on Large-Scale Electronic Health Record Notes: An Empirical Study.
    Li F; Jin Y; Liu W; Rawat BPS; Cai P; Yu H
    JMIR Med Inform; 2019 Sep; 7(3):e14830. PubMed ID: 31516126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting the progression of mild cognitive impairment to Alzheimer's disease by longitudinal magnetic resonance imaging-based dictionary learning.
    Lin Y; Huang K; Xu H; Qiao Z; Cai S; Wang Y; Huang L;
    Clin Neurophysiol; 2020 Oct; 131(10):2429-2439. PubMed ID: 32829290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiomics Blood-Based Biomarkers Predict Alzheimer's Predementia with High Specificity in a Multicentric Cohort Study.
    Souchet B; Michaïl A; Heuillet M; Dupuy-Gayral A; Haudebourg E; Pech C; Berthemy AA; Autelitano F; Billoir B; Domoto-Reilly K; Fowler C; Grabowski T; Jayadev S; Masters CL; Braudeau J
    J Prev Alzheimers Dis; 2024; 11(3):567-581. PubMed ID: 38706273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Automated Recognition of Visual Acuity Measurements in Ophthalmology Clinical Notes Using Deep Learning.
    Bernstein IA; Koornwinder A; Hwang HH; Wang SY
    Ophthalmol Sci; 2024; 4(2):100371. PubMed ID: 37868799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Med-BERT: pretrained contextualized embeddings on large-scale structured electronic health records for disease prediction.
    Rasmy L; Xiang Y; Xie Z; Tao C; Zhi D
    NPJ Digit Med; 2021 May; 4(1):86. PubMed ID: 34017034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting progression from subjective cognitive decline to mild cognitive impairment or dementia based on brain atrophy patterns.
    Lerch O; Ferreira D; Stomrud E; van Westen D; Tideman P; Palmqvist S; Mattsson-Carlgren N; Hort J; Hansson O; Westman E
    Alzheimers Res Ther; 2024 Jul; 16(1):153. PubMed ID: 38970077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of asthma control factor in clinical notes using a hybrid deep learning model.
    Agnikula Kshatriya BS; Sagheb E; Wi CI; Yoon J; Seol HY; Juhn Y; Sohn S
    BMC Med Inform Decis Mak; 2021 Nov; 21(Suppl 7):272. PubMed ID: 34753481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross-cohort generalizability of deep and conventional machine learning for MRI-based diagnosis and prediction of Alzheimer's disease.
    Bron EE; Klein S; Papma JM; Jiskoot LC; Venkatraghavan V; Linders J; Aalten P; De Deyn PP; Biessels GJ; Claassen JAHR; Middelkoop HAM; Smits M; Niessen WJ; van Swieten JC; van der Flier WM; Ramakers IHGB; van der Lugt A; ;
    Neuroimage Clin; 2021; 31():102712. PubMed ID: 34118592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma d-glutamate levels for detecting mild cognitive impairment and Alzheimer's disease: Machine learning approaches.
    Chang CH; Lin CH; Liu CY; Huang CS; Chen SJ; Lin WC; Yang HT; Lane HY
    J Psychopharmacol; 2021 Mar; 35(3):265-272. PubMed ID: 33586518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Clinically-Translatable Machine Learning Algorithm for the Prediction of Alzheimer's Disease Conversion in Individuals with Mild and Premild Cognitive Impairment.
    Grassi M; Perna G; Caldirola D; Schruers K; Duara R; Loewenstein DA
    J Alzheimers Dis; 2018; 61(4):1555-1573. PubMed ID: 29355115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of Machine Learning to Arterial Spin Labeling in Mild Cognitive Impairment and Alzheimer Disease.
    Collij LE; Heeman F; Kuijer JP; Ossenkoppele R; Benedictus MR; Möller C; Verfaillie SC; Sanz-Arigita EJ; van Berckel BN; van der Flier WM; Scheltens P; Barkhof F; Wink AM
    Radiology; 2016 Dec; 281(3):865-875. PubMed ID: 27383395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation study of the Alzheimer's Disease Assessment Scale-Cognitive Subscale for people with mild cognitive impairment and Alzheimer's disease in Chinese communities.
    Yang H; Cheng Z; Li Z; Jiang Y; Zhao J; Wu Y; Gu S; Xu H
    Int J Geriatr Psychiatry; 2019 Nov; 34(11):1658-1666. PubMed ID: 31347192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer's disease dementia.
    Arbizu J; Prieto E; Martínez-Lage P; Martí-Climent JM; García-Granero M; Lamet I; Pastor P; Riverol M; Gómez-Isla MT; Peñuelas I; Richter JA; Weiner MW;
    Eur J Nucl Med Mol Imaging; 2013 Sep; 40(9):1394-405. PubMed ID: 23715905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validity of the MemTrax Memory Test Compared to the Montreal Cognitive Assessment in the Detection of Mild Cognitive Impairment and Dementia due to Alzheimer's Disease in a Chinese Cohort.
    Liu X; Chen X; Zhou X; Shang Y; Xu F; Zhang J; He J; Zhao F; Du B; Wang X; Zhang Q; Zhang W; Bergeron MF; Ding T; Ashford JW; Zhong L
    J Alzheimers Dis; 2021; 80(3):1257-1267. PubMed ID: 33646151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resting state EEG biomarkers of cognitive decline associated with Alzheimer's disease and mild cognitive impairment.
    Meghdadi AH; Stevanović Karić M; McConnell M; Rupp G; Richard C; Hamilton J; Salat D; Berka C
    PLoS One; 2021; 16(2):e0244180. PubMed ID: 33544703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk Stratification Using Cerebrospinal Fluid Biomarkers in Patients with Mild Cognitive Impairment: An Exploratory Analysis.
    Michaud TL; Kane RL; McCarten JR; Gaugler JE; Nyman JA; Kuntz KM;
    J Alzheimers Dis; 2015; 47(3):729-40. PubMed ID: 26401707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease.
    Haris M; Yadav SK; Rizwan A; Singh A; Cai K; Kaura D; Wang E; Davatzikos C; Trojanowski JQ; Melhem ER; Marincola FM; Borthakur A
    Neuroimage Clin; 2015; 7():598-604. PubMed ID: 25844314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.